SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-044585
Filing Date
2023-08-25
Accepted
2023-08-25 16:21:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a_notice_access_no.htm DEFA14A 27593
2 GRAPHIC img209424466_0.jpg GRAPHIC 756679
3 GRAPHIC img209424466_1.jpg GRAPHIC 753953
  Complete submission text file 0000950170-23-044585.txt   2108322
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-35776 | Film No.: 231208541
SIC: 2834 Pharmaceutical Preparations